CDC Renews Injury Prevention Board: Yawn, Business as Usual
Published Date: 3/4/2026
Notice
Summary
The CDC just renewed the Board of Scientific Counselors for the National Center for Injury Prevention and Control’s charter for two more years, keeping their important work going through January 13, 2028. This means the board will keep advising on injury prevention strategies that affect public health, with no new costs announced. The renewal ensures the board stays active and ready to tackle injury-related challenges ahead.
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
Injury Prevention Board Charter Renewed
The CDC renewed the charter for the Board of Scientific Counselors for the National Center for Injury Prevention and Control for a two-year period, keeping the board active through January 13, 2028. The notice states that no new costs were announced with this renewal.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-06231 — Agency Forms Undergoing Paperwork Reduction Act Review
The CDC is asking for your thoughts on a survey about blood collection and use. They want to make sure the questions are clear, useful, and not too much work for people to answer. You’ve got 30 days to share your ideas before they finalize the forms, helping save time and money for everyone involved.
2026-06232 — Proposed Data Collection Submitted for Public Comment and Recommendations
The CDC wants your thoughts on new forms to keep research data super safe when sharing secret info for important studies. This affects researchers who need access to private data and helps protect everyone’s privacy without adding extra hassle. You’ve got until June 1, 2026, to share your ideas—no cost changes, just smarter security!
2026-05948 — Advisory Committee on Immunization Practices; Cancellation of Meeting
The Advisory Committee on Immunization Practices (ACIP) meeting set for March 18-19, 2026, has been canceled for now due to a court order. This affects healthcare experts and the public waiting on vaccine advice, delaying any new immunization updates. No costs or new dates are announced yet, so stay tuned for when the meeting will happen next!
2026-05421 — World Trade Center (WTC) Health Program; Petition 026-Anti-Glomerular Basement Membrane (Anti-GBM) Glomerulonephritis; Finding of Insufficient Evidence
The WTC Health Program reviewed a request to add Anti-GBM Glomerulonephritis, a kidney disease, to its list of covered health conditions but found not enough proof to do so. This means people affected by this disease won’t get new benefits or coverage changes right now. The decision was made official on March 19, 2026, with no immediate money or timing changes.
2026-05136 — Solicitation of Nominations for Appointment to the Advisory Committee on Breast Cancer in Young Women
The CDC is looking for smart and passionate people to join a special team focused on breast cancer in young women. If you’re an expert or survivor under 45, you can apply by April 20, 2026, to help shape prevention, treatment, and support efforts. This is a great chance to make a real difference without any pay but with a big impact on health policies.
2026-05195 — Agency Forms Undergoing Paperwork Reduction Act Review
The CDC is asking for your thoughts on their new forms about health and air travel. They want to make sure these forms are useful, clear, and not too much work for people to fill out. You’ve got 30 days to share your ideas before the government decides, so don’t miss out!
Previous / Next Documents
Previous: 2026-04236 — Notice of Receipt of Complaint; Solicitation of Comments Relating to the Public Interest
The U.S. International Trade Commission got a complaint from Genentech about certain pertuzumab biosimilars being imported and sold in the U.S. They want to stop these products because of patent issues. The Commission is asking the public to share their thoughts on how this might affect everyone, with decisions and possible actions happening soon, including a 60-day review period.
Next: 2026-04238 — Proposed Collection; 60-Day Comment Request; Regular Clearance for the National Institute of Mental Health Data Archive (NDA), (NIMH)
The National Institute of Mental Health (NIMH) wants to keep collecting important mental health data through its Data Archive and is asking the public to share their thoughts by May 4, 2026. This helps make sure the data collection is useful, clear, and not too much work for those involved. No big changes or costs are expected, just a smooth extension to keep the research going strong.
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in